Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation

Identification of putative allosteric inhibitors of BCKDK via virtual screening and biological evaluation

AbstractAbnormal accumulation of branched-chain amino acids (BCAAs) can lead to metabolic diseases and cancers. Branched-chain α-keto acid dehydrogenase kinase (BCKDK) is a key negative regulator of BCAA catabolism, and targeting BCKDK provides a promising therapeutic approach for diseases caused by...

Full description

Bibliographic Details
Main Authors:	Chunqiong Li, Quanjun Yang, Li Zhang
Format:	Article
Language:	English
Published:	Taylor & Francis Group 2024-12-01
Series:	Journal of Enzyme Inhibition and Medicinal Chemistry
Subjects:	BCKDK allosteric inhibitors virtual screening BCAA metabolism metabolic diseases and cancer treatment
Online Access:	https://www.tandfonline.com/doi/10.1080/14756366.2023.2290458

Similar Items

Novel Loss of Function Variant in BCKDK Causes a Treatable Developmental and Epileptic Encephalopathy
by: François Boemer, et al.
Published: (2022-02-01)

Recent Advances in the Discovery of CK2 Allosteric Inhibitors: From Traditional Screening to Structure-Based Design
by: Xiaolan Chen, et al.
Published: (2020-02-01)

Loss of BCAA catabolism enhances Rab1A-mTORC1 signaling activity and promotes tumor proliferation in NSCLC
by: Meiting Xue, et al.
Published: (2023-08-01)

Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model
by: Veronika Voronova, et al.
Published: (2022-11-01)

Identification and Biological Evaluation of CK2 Allosteric Fragments through Structure-Based Virtual Screening
by: Chunqiong Li, et al.
Published: (2020-01-01)

BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer
by: Peipei Xue, et al.
Published: (2017-06-01)

The Discovery of Small Allosteric and Active Site Inhibitors of the SARS-CoV-2 Main Protease via Structure-Based Virtual Screening and Biological Evaluation
by: Radwa E. Mahgoub, et al.
Published: (2022-10-01)

Virtual Screening for Potential Allosteric Inhibitors of Cyclin-Dependent Kinase 2 from Traditional Chinese Medicine
by: Fang Lu, et al.
Published: (2016-09-01)

Probing Allosteric Hsp70 Inhibitors by Molecular Modelling Studies to Expedite the Development of Novel Combined F508del CFTR Modulators
by: Roberto Sabbadini, et al.
Published: (2021-12-01)

BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice
by: Eliza Bollinger, et al.
Published: (2022-12-01)

Repositioning Dequalinium as Potent Muscarinic Allosteric Ligand by Combining Virtual Screening Campaigns and Experimental Binding Assays
by: Angelica Mazzolari, et al.
Published: (2020-08-01)

Plasmin Regulation through Allosteric, Sulfated, Small Molecules
by: Rami A. Al-Horani, et al.
Published: (2015-01-01)

Discovery of Novel Allosteric Modulators Targeting an Extra-Helical Binding Site of GLP-1R Using Structure- and Ligand-Based Virtual Screening
by: Qingtong Zhou, et al.
Published: (2021-06-01)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

Design, synthesis and biological evaluation of novel triazoloquinazolinone and imidazoquinazolinone derivatives as allosteric inhibitors of SHP2 phosphatase
by: Wenjun Ye, et al.
Published: (2022-05-01)

Systematic Analysis of Covalent and Allosteric Protein Kinase Inhibitors
by: Elena Xerxa, et al.
Published: (2023-08-01)

Dynamically Shaping Chaperones. Allosteric Modulators of HSP90 Family as Regulatory Tools of Cell Metabolism in Neoplastic Progression
by: Carlos Sanchez-Martin, et al.
Published: (2020-07-01)

Enhancement of Inhibitory Activity by Combining Allosteric Inhibitors Putatively Binding to Different Allosteric Sites on Cathepsin K
by: Shun Sato, et al.
Published: (2023-05-01)

In Silico Discovery and Optimisation of a Novel Structural Class of Hsp90 C-Terminal Domain Inhibitors
by: Živa Zajec, et al.
Published: (2022-06-01)

An unconventional gatekeeper mutation sensitizes inositol hexakisphosphate kinases to an allosteric inhibitor
by: Tim Aguirre, et al.
Published: (2023-10-01)

Permethrin as a Potential Furin Inhibitor through a Novel Non-Competitive Allosteric Inhibition
by: Dongyan Feng, et al.
Published: (2023-02-01)

Transcription factor-based biosensors for screening and dynamic regulation
by: Jonathan Tellechea-Luzardo, et al.
Published: (2023-02-01)

Identification of Leishmania major UDP-Sugar Pyrophosphorylase Inhibitors Using Biosensor-Based Small Molecule Fragment Library Screening
by: Ohm Prakash, et al.
Published: (2019-03-01)

Druggable cavities and allosteric modulators of the cell division cycle 7 (CDC7) kinase
by: Elisa Rojas-Prats, et al.
Published: (2024-12-01)

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico
by: Jakob Fleischmann, et al.
Published: (2021-03-01)

Allosteric enzymes /
by: Herve, Guy
Published: (1989)

Molecular basis for allosteric specificity regulation in class Ia ribonucleotide reductase from Escherichia coli
by: Christina M Zimanyi, et al.
Published: (2016-01-01)

Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing
by: Berin Karaman, et al.
Published: (2018-02-01)

Dietary branched-chain amino acids intake, glycemic markers, metabolic profile, and anthropometric features in a community-based sample of overweight and obese adults
by: Ensiye Soleimani, et al.
Published: (2023-09-01)

Branched-Chain Amino Acids (BCAAs) - oral supplementation and its effects in resistance training and treatment
by: Borys Bieńkowski, et al.
Published: (2023-08-01)

Meta-analysis links dietary branched-chain amino acids to metabolic health in rodents
by: Samantha M. Solon-Biet, et al.
Published: (2022-01-01)

Identification of new allosteric sites and modulators of AChE through computational and experimental tools
by: Carlos Roca, et al.
Published: (2018-01-01)

Structure-activity exploration of a small-molecule allosteric inhibitor of T790M/L858R double mutant EGFR
by: Francesca Foschi, et al.
Published: (2023-12-01)

Uncovering an allosteric mode of action for a selective inhibitor of human Bloom syndrome protein
by: Xiangrong Chen, et al.
Published: (2021-03-01)

In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators
by: Jiayi Yuan, et al.
Published: (2022-01-01)

Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors
by: Jian Sun, et al.
Published: (2024-01-01)

Allosteric Inhibitors of NMDA Receptor Functions
by: William F. Borschel, et al.
Published: (2010-10-01)

The Search for Antibacterial Inhibitors Targeting Cell Division Protein FtsZ at Its Nucleotide and Allosteric Binding Sites
by: José M. Andreu, et al.
Published: (2022-07-01)

In Silico Identification and Experimental Validation of (−)-Muqubilin A, a Marine Norterpene Peroxide, as PPARα/γ-RXRα Agonist and RARα Positive Allosteric Modulator
by: Enrico D’Aniello, et al.
Published: (2019-02-01)

Specific Amino Acids Affect Cardiovascular Diseases and Atherogenesis via Protection against Macrophage Foam Cell Formation: Review Article
by: Claudia Grajeda-Iglesias, et al.
Published: (2018-07-01)